111 related articles for article (PubMed ID: 37384907)
21. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
22. Hyperexpression of Integrin α5β1 Promotes Resistance of MCF-7 Human Breast Carcinoma Cells to Doxorubicin via ERK Protein Kinase Down-regulation.
Morozevich GE; Kozlova NI; Susova OY; Lupatov AY; Berman AE
Biochemistry (Mosc); 2017 Sep; 82(9):1017-1024. PubMed ID: 28988530
[TBL] [Abstract][Full Text] [Related]
23. Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathway.
Xiao Q; Ying J; Qiao Z; Yang Y; Dai X; Xu Z; Zhang C; Xiang L
J Dermatol Sci; 2020 Apr; 98(1):26-34. PubMed ID: 32098704
[TBL] [Abstract][Full Text] [Related]
24. Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway.
Lee DY; Li YS; Chang SF; Zhou J; Ho HM; Chiu JJ; Chien S
J Biol Chem; 2010 Jan; 285(1):30-42. PubMed ID: 19889638
[TBL] [Abstract][Full Text] [Related]
25. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src/Akt/mTOR/cofilin signaling pathway.
Li J; Yang R; Yang H; Chen S; Wang L; Li M; Yang S; Feng Z; Bi J
J Cell Biochem; 2020 Feb; 121(2):1192-1204. PubMed ID: 31468584
[TBL] [Abstract][Full Text] [Related]
26. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.
Astle MV; Hannan KM; Ng PY; Lee RS; George AJ; Hsu AK; Haupt Y; Hannan RD; Pearson RB
Oncogene; 2012 Apr; 31(15):1949-62. PubMed ID: 21909130
[TBL] [Abstract][Full Text] [Related]
27. Conformation-dependent binding of a Tetrastatin peptide to α
Lambert E; Fuselier E; Ramont L; Brassart B; Dukic S; Oudart JB; Dupont-Deshorgue A; Sellier C; Machado C; Dauchez M; Monboisse JC; Maquart FX; Baud S; Brassart-Pasco S
Sci Rep; 2018 Jun; 8(1):9837. PubMed ID: 29959360
[TBL] [Abstract][Full Text] [Related]
28. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
29. Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells.
Park JH; Kim JJ; Bae YS
Biochem Biophys Res Commun; 2013 Apr; 433(4):420-5. PubMed ID: 23523798
[TBL] [Abstract][Full Text] [Related]
30. Implication of alpha5beta1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells: a role for MMP-2 collagenase.
Morozevich GE; Kozlova NI; Cheglakov IB; Ushakova NA; Preobrazhenskaya ME; Berman AE
Biochemistry (Mosc); 2008 Jul; 73(7):791-6. PubMed ID: 18707587
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1.
Zhang X; Groopman JE; Wang JF
J Cell Physiol; 2005 Jan; 202(1):205-14. PubMed ID: 15389531
[TBL] [Abstract][Full Text] [Related]
32. Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells.
Morozevich GE; Kozlova NI; Ushakova NA; Preobrazhenskaya ME; Berman AE
Aging (Albany NY); 2012 May; 4(5):368-74. PubMed ID: 22626691
[TBL] [Abstract][Full Text] [Related]
33. Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling.
Lee JH; Won YS; Park KH; Lee MK; Tachibana H; Yamada K; Seo KI
Apoptosis; 2012 Dec; 17(12):1275-86. PubMed ID: 23065091
[TBL] [Abstract][Full Text] [Related]
34. Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.
McKenzie JA; Liu T; Goodson AG; Grossman D
Cancer Res; 2010 Oct; 70(20):7927-37. PubMed ID: 20807805
[TBL] [Abstract][Full Text] [Related]
35. AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.
Brolih S; Parks SK; Vial V; Durivault J; Mostosi L; Pouysségur J; Pagès G; Picco V
BMC Cancer; 2018 Mar; 18(1):249. PubMed ID: 29506489
[TBL] [Abstract][Full Text] [Related]
36. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
37. Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A.
Mazzio EA; Soliman KFA
Cancer Genomics Proteomics; 2018; 15(5):349-364. PubMed ID: 30194076
[TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
39. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
[TBL] [Abstract][Full Text] [Related]
40. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
Renner G; Noulet F; Mercier MC; Choulier L; Etienne-Selloum N; Gies JP; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
Oncotarget; 2016 Sep; 7(38):62194-62207. PubMed ID: 27613837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
